 | • レポートコード：MRC2305A019 • 出版社/出版日：Transparency Market Research / 2023年3月8日 • レポート形態：英文、PDF、170ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートによると、世界の心房細動手術装置市場規模が、2022年の21億ドルから2031年に70億ドルとなり、予測期間中に年平均14%で成長すると推測されています。本レポートは、心房細動手術装置の世界市場について徹底的に分析・調査を行い、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、主要インサイト、手術別（カテーテルアブレーション、外科的アブレーション）分析、エンドユーザー別（病院、専門センター、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の項目を整理しています。また、Abbott Laboratories.、Biosense Webster, Inc.、Medtronic plc、Boston Scientific Corporation、CardioFocus, Inc.、AtriCure, Inc.、Osypka AG、Kardium, Inc.、Acutus Medical, Inc.、Koninklijke Philips N.V.など、主要企業情報を含んでいます。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の心房細動手術装置市場規模：手術別 - カテーテルアブレーションの市場規模 - 外科的アブレーションの市場規模 ・世界の心房細動手術装置市場規模：エンドユーザー別 - 病院における市場規模 - 専門センターにおける市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の心房細動手術装置市場規模：地域別 - 北米の心房細動手術装置市場規模 - ヨーロッパの心房細動手術装置市場規模 - アジア太平洋の心房細動手術装置市場規模 - 中南米の心房細動手術装置市場規模 - 中東・アフリカの心房細動手術装置市場規模 ・競争状況 |
Atrial Fibrillation Surgery Devices Market – Scope of Report
TMR’s report on the global atrial fibrillation surgery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global atrial fibrillation surgery devices market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atrial fibrillation surgery devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the atrial fibrillation surgery devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atrial fibrillation surgery devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global atrial fibrillation surgery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atrial fibrillation surgery devices market.
The report delves into the competitive landscape of the global atrial fibrillation surgery devices market. Key players operating in the global atrial fibrillation surgery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global atrial fibrillation surgery devices market profiled in this report.
Key Questions Answered in Global Atrial Fibrillation Surgery Devices Market Report
• What is the sales/revenue generated by atrial fibrillation surgery devices across all regions during the forecast period?
• What are the opportunities in the global atrial fibrillation surgery devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Atrial Fibrillation Surgery Devices Market – Research Objectives and Research Approach
The comprehensive report on the global atrial fibrillation surgery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global atrial fibrillation surgery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global atrial fibrillation surgery devices market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Atrial Fibrillation Surgery Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Procedure Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, 2017–2031
4.4.1. Porter’s Five Forces Analysis
5. Key Insights
5.1. Disease Prevalence & Incidence Rate Globally With Key Countries
5.2. Technological Advancements
5.3. Overview of Atrial Fibrillation
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Procedure
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Procedure, 2017–2031
6.3.1. Catheter Ablation
6.3.1.1. Radiofrequency Ablation
6.3.1.2. Cryoablation
6.3.2. Surgical Ablation
6.3.2.1. Convergent Ablation
6.3.2.2. Maze Ablation
6.4. Market Attractiveness Analysis, by Procedure
7. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Specialty Centers
7.3.3. Ambulatory Surgical Centers
7.3.4. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Atrial Fibrillation Surgery Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Procedure, 2017–2031
9.2.1. Catheter Ablation
9.2.1.1. Radiofrequency Ablation
9.2.1.2. Cryoablation
9.2.2. Surgical Ablation
9.2.2.1. Convergent Ablation
9.2.2.2. Maze Ablation
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Specialty Centers
9.3.3. Ambulatory Surgical Centers
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Procedure
9.5.2. By End-user
9.5.3. By Country
10. Europe Atrial Fibrillation Surgery Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Procedure, 2017–2031
10.2.1. Catheter Ablation
10.2.1.1. Radiofrequency Ablation
10.2.1.2. Cryoablation
10.2.2. Surgical Ablation
10.2.2.1. Convergent Ablation
10.2.2.2. Maze Ablation
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Specialty Centers
10.3.3. Ambulatory Surgical Centers
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Procedure
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Atrial Fibrillation Surgery Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Procedure, 2017–2031
11.2.1. Catheter Ablation
11.2.1.1. Radiofrequency Ablation
11.2.1.2. Cryoablation
11.2.2. Surgical Ablation
11.2.2.1. Convergent Ablation
11.2.2.2. Maze Ablation
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Specialty Centers
11.3.3. Ambulatory Surgical Centers
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Procedure
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Atrial Fibrillation Surgery Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Procedure, 2017–2031
12.2.1. Catheter Ablation
12.2.1.1. Radiofrequency Ablation
12.2.1.2. Cryoablation
12.2.2. Surgical Ablation
12.2.2.1. Convergent Ablation
12.2.2.2. Maze Ablation
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Specialty Centers
12.3.3. Ambulatory Surgical Centers
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Procedure
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Atrial Fibrillation Surgery Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Procedure, 2017–2031
13.2.1. Catheter Ablation
13.2.1.1. Radiofrequency Ablation
13.2.1.2. Cryoablation
13.2.2. Surgical Ablation
13.2.2.1. Convergent Ablation
13.2.2.2. Maze Ablation
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Specialty Centers
13.3.3. Ambulatory Surgical Centers
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Procedure
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. AtriCure, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. CardioFocus, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Abbott Laboratories
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Biosense Webster, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Medtronic plc
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.6. Boston Scientific Corporation
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.7. Osypka AG
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.8. Kardium, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.9. Acutus Medical, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.10. Koninklijke Philips N.V.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview